Gain Therapeutics Inc (GANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 303 | 0 |
| Receivables | 8 | 0 |
| Other current assets | 119 | 0 |
| TOTAL | $430 | $0 |
| Non-Current Assets | ||
| Other Non-Current Assets | 11 | 0 |
| TOTAL | $11 | $N/A |
| Total Assets | $660 | $0 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 154 | 0 |
| Other current liabilities | 619 | 0 |
| TOTAL | $879 | $0 |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 132 | 0 |
| TOTAL | $132 | $N/A |
| Total Liabilities | $1,110 | $0 |
| Shareholders' Equity | ||
| Retained earnings | -1,264 | 0 |
| Other shareholders' equity | -2,274 | 0 |
| TOTAL | $-450 | $0 |
| Total Liabilities And Equity | $660 | $0 |